STOCK TITAN

Northrop Grumman SEC Filings

NOC NYSE

Welcome to our dedicated page for Northrop Grumman SEC filings (Ticker: NOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Northrop Grumman Corporation filings document formal disclosures for an NYSE-listed aerospace and defense contractor with common stock trading under NOC. Recent 8-K reports furnish quarterly and annual earnings releases, summarize operating results and awards, and record material events such as director elections, officer transitions, compensation actions and credit-facility agreements.

The company's proxy materials describe board structure, committee assignments, executive compensation and annual meeting governance. Its financing disclosures cover senior unsecured revolving credit arrangements, commercial paper support, covenants, events of default and capital-structure terms relevant to the company's defense and space systems operations.

Rhea-AI Summary

Northrop Grumman Corporation reported the final voting results from its 2026 Annual Meeting of Shareholders. Shareholders elected eleven directors to the board, including Chair and CEO Kathy J. Warden and ten other nominees, each receiving a substantial majority of votes cast in favor.

On an advisory basis, shareholders approved the compensation of the company’s named executive officers, with 107,398,463 votes for, 5,220,362 against and 851,475 abstentions. Shareholders also ratified Deloitte & Touche LLP as independent auditor for the fiscal year ending December 31, 2026, with 121,265,768 votes for, 5,116,361 against and 373,605 abstentions.

A shareholder proposal to require an independent board chair did not pass, receiving 23,610,695 votes for and 88,773,053 against, with 1,086,552 abstentions. The board stated it will carefully consider shareholder input and feedback received through engagement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
current report
-
Rhea-AI Summary

Northrop Grumman director Mary A. Winston reported a compensation-related stock award rather than an open-market trade. She received 349 shares of common stock on May 20, 2026 as a grant or award at $552.17 per share, with the shares deferred into a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3. After this acquisition, she directly holds 1,609 shares of common stock and indirectly holds 9 shares in an IRA. A footnote explains that her total amount also includes 78 shares of common stock and 1,540 shares of common stock equivalents, including dividends, held in stock unit accounts under current and prior long-term incentive plans.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
insider
-
Rhea-AI Summary

WELSH MARK A III reported acquisition or exercise transactions in this Form 4 filing.

Northrop Grumman director Mark A. Welsh III received a grant of 349 shares of common stock on May 20, 2026. The award was priced at $552.17 per share and was deferred into a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3.

After this award, he beneficially holds 4,470 shares and stock units in total, including 488 shares of common stock and 3,982 shares of common stock equivalents, including dividends, in stock unit accounts under the company’s long-term incentive plans.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
insider
Rhea-AI Summary

Turley James S reported acquisition or exercise transactions in this Form 4 filing.

Northrop Grumman director James S. Turley received an award of 349 shares of Common Stock valued at $552.17 per share. The shares were deferred into a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3.

After this award, Turley holds a total of 6,738 shares, including 635 shares of common stock and 6,103 shares of common stock equivalents, including dividends, in stock unit accounts under the company’s current and 2011 long-term incentive stock plans.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
insider
-
Rhea-AI Summary

SCHOEWE THOMAS M reported acquisition or exercise transactions in this Form 4 filing.

Northrop Grumman Corp. director Thomas M. Schoewe received an award of 349 shares of common stock-equivalent units on May 20, 2026. The grant was priced at $552.17 per share and was made under the Northrop Grumman 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3.

After this award, Schoewe’s holdings total 16,737 share equivalents, including 3,160 shares of common stock and 13,577 stock units (with dividends) held in plan-related stock unit accounts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
insider
-
Rhea-AI Summary

Northrop Grumman director Gary Roughead received an equity award of 349 common shares, valued at $552.17 per share, as a grant under the company’s long-term incentive plan. After this award, he directly holds 12,210 common shares. The shares were deferred into a stock unit account under Northrop Grumman’s 2024 Long-Term Incentive Stock Plan and are treated as an acquisition exempt from short-swing profit rules. Footnotes note that additional stock units, including dividend equivalents under current and prior long-term incentive plans, are maintained in this account but were not part of this new grant.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
insider
Rhea-AI Summary

Ross Kimberly A. reported acquisition or exercise transactions in this Form 4 filing.

Northrop Grumman director Kimberly A. Ross received an equity award of 349 shares of common stock, valued at $552.17 per share, as compensation. The shares were deferred into a stock unit account under Northrop Grumman’s 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3. After this grant, Ross directly holds 1,612 shares, including dividends credited in stock unit accounts under the 2024 plan and the earlier 2011 Long-Term Incentive Stock Plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
insider
-
Rhea-AI Summary

KRISHNA ARVIND reported acquisition or exercise transactions in this Form 4 filing.

Northrop Grumman director Arvind Krishna received an award of 349 shares of common stock on May 20, 2026, at a reference price of $552.17 per share. The filing explains these shares were deferred into a stock unit account under Northrop Grumman’s 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3. After this grant, Krishna directly holds 2,666 shares of common stock, including shares and dividends accumulated in stock unit accounts under the company’s long‑term incentive plans.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
insider
-
Rhea-AI Summary

Northrop Grumman director Christopher W. Grady reported a compensation-related stock award. On May 20, 2026, he acquired 349 shares of Common Stock at a stated value of $552.17 per share through a grant under the Northrop Grumman 2024 Long-Term Incentive Stock Plan.

These shares were deferred into a stock unit account in a transaction exempt under Rule 16b-3. Following the award, Grady directly holds 421 shares of Northrop Grumman common stock, including amounts and dividends maintained in the stock unit account pursuant to the company’s long-term incentive plans.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
insider
Rhea-AI Summary

Brown Marianne Catherine reported acquisition or exercise transactions in this Form 4 filing.

Northrop Grumman director Marianne Catherine Brown received a grant of 349 shares of common stock on May 20, 2026, as a compensation award. The shares were deferred into a stock unit account under Northrop Grumman’s 2024 Long-Term Incentive Stock Plan in a transaction exempt under Rule 16b-3.

After this award, Brown directly holds a total of 11,415 shares of Northrop Grumman common stock, including shares and dividends held in stock unit accounts under the company’s long-term incentive plans.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
insider

FAQ

How many Northrop Grumman (NOC) SEC filings are available on StockTitan?

StockTitan tracks 85 SEC filings for Northrop Grumman (NOC), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Northrop Grumman (NOC)?

The most recent SEC filing for Northrop Grumman (NOC) was filed on May 21, 2026.